Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Circulation|February 7, 2001
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention StudyD J Freeman, J Norrie, N Sattar, et al.Brain : a Journal of Neurology|February 29, 2008
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.Journal of Electrocardiology|March 10, 2001
Standards for the function of an academic 12-lead electrocardiographic core laboratoryS T Anderson, O Pahlm, L Bacharova, et al.Experimental Gerontology|May 28, 2008
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.Diabetologia|November 26, 2008
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderlyN Sattar, H M Murray, P Welsh, et al.The American Journal of Cardiology|November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at RiskJ Shepherd, G J Blauw, M B Murphy, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at RiskP J Houx, J Shepherd, G-J Blauw, et al.Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.Plos One|May 20, 2022
Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortiumJ E Siland, B Geelhoed, C Roselli, et al.The Pharmacogenomics Journal|March 6, 2013
Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT intervalC L Avery, C M Sitlani, D E Arking, et al.Pageof 15